Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center

Skala Kavanagh, Hana; Ćavar, Stipe; Grubišić, Frane; Doko Vajdić, Ines; Kraljević, Jadranka; Glavaš, Dragan; Grazio, Simeon

doi:10.33004/reumatizam-supp-71-1-21

Reumatizam, Vol. 71 No. Supp 1, 2024.

Meeting abstract

https://doi.org/10.33004/reumatizam-supp-71-1-21

Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center

Hana Skala Kavanagh orcid.org/0000-0002-9340-0809 *
Stipe Ćavar
Frane Grubišić
Ines Doko Vajdić
Jadranka Kraljević
Dragan Glavaš
Simeon Grazio

* Corresponding author.

Full text: croatian pdf 651 Kb

page 23-24

downloads: 44

cite

APA 6th Edition

Skala Kavanagh, H., Ćavar, S., Grubišić, F., Doko Vajdić, I., Kraljević, J., Glavaš, D. & Grazio, S. (2024). Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center. Reumatizam, 71 (Supp 1). https://doi.org/10.33004/reumatizam-supp-71-1-21

MLA 8th Edition

Skala Kavanagh, Hana, et al. "Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center." Reumatizam, vol. 71, no. Supp 1, 2024 https://doi.org/10.33004/reumatizam-supp-71-1-21. Accessed 29 Dec. 2024.

Chicago 17th Edition

Skala Kavanagh, Hana, Stipe Ćavar, Frane Grubišić, Ines Doko Vajdić, Jadranka Kraljević, Dragan Glavaš and Simeon Grazio. "Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center." Reumatizam 71, no. Supp 1 https://doi.org/10.33004/reumatizam-supp-71-1-21

Harvard

Skala Kavanagh, H., et al. (2024). 'Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center', Reumatizam, 71(Supp 1). https://doi.org/10.33004/reumatizam-supp-71-1-21

Vancouver

Skala Kavanagh H, Ćavar S, Grubišić F, Doko Vajdić I, Kraljević J, Glavaš D, et al. Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center. Reumatizam [Internet]. 2024 [cited 2024 December 29];71(Supp 1). https://doi.org/10.33004/reumatizam-supp-71-1-21

IEEE

H. Skala Kavanagh, et al., "Persistence and reasons for discontinuation of therapy with IL-17 or TNF-ALPHA inhibitors in patients with psoriatic arthritis – Experience of a tertiary center", Reumatizam, vol.71, no. Supp 1, 2024. [Online]. https://doi.org/10.33004/reumatizam-supp-71-1-21

Abstract

Keywords

Hrčak ID:

322090

URI

https://hrcak.srce.hr/322090

Publication date:

24.10.2024.

Article data in other languages: croatian

Visits: 118 *

Login and registration

Reumatizam, Vol. 71 No. Supp 1, 2024.

Abstract

Keywords

Hrčak ID:

URI

Publication date: